The ACURE Trial: Acupuncture for Colorectal Recovery
NCT: NCT07496528 · NOT_YET_RECRUITING
Brief Summary
Purpose: The goal of this clinical trial is to evaluate whether electroacupuncture (EA) can accelerate the recovery of bowel function in patients undergoing minimally invasive surgery for colorectal cancer. Main Questions to be Answered: Does electroacupuncture reduce the time to the first bowel movement after surgery compared to standard care or a "sham" (placebo) treatment? Can electroacupuncture improve overall gastrointestinal tolerance and reduce postoperative discomfort? Study Design: Participants will be randomly assigned to one of three groups: Electroacupuncture Group: Receives active electrical stimulation at specific acupuncture points. Sham Acupuncture Group: Receives superficial needling at non-treatment points with no electrical current to serve as a placebo. Standard Care Group: Receives standard hospital recovery protocols (ERAS) without acupuncture. All treatments will consist of four 30-minute sessions: one before surgery and three on the days following the procedure. Researchers will compare the three groups to see if the electroacupuncture group experiences a faster return of digestive function.
Frequently Asked Questions
What is The ACURE Trial: Acupuncture for Colorectal Recovery?
The ACURE Trial: Acupuncture for Colorectal Recovery is a clinical trial registered under NCT07496528. Current status: NOT_YET_RECRUITING.
What is the status of NCT07496528?
The current status of NCT07496528 (The ACURE Trial: Acupuncture for Colorectal Recovery) is: NOT_YET_RECRUITING.
When did The ACURE Trial: Acupuncture for Colorectal Recovery start?
The ACURE Trial: Acupuncture for Colorectal Recovery started on 2026-04-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.